Atlas Venture Fund Xi, L.P. is > 10% Shareholder of Ikena Oncology, Inc.. Currently has a direct ownership of 1.24 Million shares of IKNA, which is worth approximately $1.73 Million. The most recent transaction as insider was on Dec 14, 2021, when has been sold 5,959 shares (Common Stock) at a price of $14.0 per share, resulting in proceeds of $83,426. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.24M
0% 3M change
0% 12M change
Total Value Held $1.73 Million

Atlas Venture Fund XI, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2021
SELL
Open market or private sale
$83,426 $14.0 p/Share
5,959 Reduced 0.48%
1,241,935 Common Stock
Dec 13 2021
SELL
Open market or private sale
$121,951 $14.64 p/Share
8,330 Reduced 0.66%
1,247,894 Common Stock
Dec 10 2021
SELL
Open market or private sale
$180,195 $15.03 p/Share
11,989 Reduced 0.95%
1,256,224 Common Stock

Also insider at

DAWN
Day One Biopharmaceuticals, Inc. Healthcare
DYN
Dyne Therapeutics, Inc. Healthcare
XLO
Xilio Therapeutics, Inc. Healthcare
THRD
Third Harmonic Bio, Inc. Healthcare
SION
Sionna Therapeutics, Inc.
AVF

Atlas Venture Fund Xi, L.P.

> 10% Shareholder
Cambridge, MA

Track Institutional and Insider Activities on IKNA

Follow Ikena Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IKNA shares.

Notify only if
Any

Insider Trading

Get notified when an Ikena Oncology, Inc. insider buys or sells IKNA shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Ikena Oncology, Inc.

Track Activities on IKNA